Chamber, Drugmakers Back AbbVie In $448M FTC Fine Appeal
Drugmakers and the U.S. Chamber of Commerce urged the Third Circuit on Wednesday to overturn a ruling that slammed AndroGel maker AbbVie with $448 million in penalties for bringing "sham" patent...To view the full article, register now.
Already a subscriber? Click here to view full article